COPD trials in Latvia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  Where

  Daugavpils, Riga

  Age

  40 years to 80 years

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190209 · EU 2024-518016-39-00
• Phase 3Taking people
  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  Where

  Daugavpils, Riga

  Age

  40 years to 80 years

  People

  961 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT06961214 · EU 2024-520417-41-00